Jio BlackRock NFOs draw 67,000 retail investors, 90+ institutions
JioBlackRock Mutual Fund's debut NFOs saw robust investor participation, with over 67,000 retail investors and more than 90 institutional investors subscribing. The fund house raised Rs 17,800 crore across three schemes, reflecting strong confidence in its digital-first, data-driven investment approach. The company aims to simplify access via the JioFinance and MyJio apps, signaling a tech-led investing shift.
ETMarkets.com JioBlackRock Mutual Fund: JioBlackRock's debut NFOs raise Rs 17,800 crore from 67,000 retail and 90+ institutional investors. JioBlackRock Mutual Fund, which launched three new fund offers (NFOs), received an overwhelming response from retail investors, with over 67,000 individuals investing during the offer period. The fund also attracted investments from more than 90 institutional investors.According to the fund house, the participation from over 90 institutions reflects confidence in JioBlackRock Asset Management's value proposition, which combines data-driven investing with a digital-first approach.
Also Read | Mutual fund SIP guide: How to invest for the rest of 2025
JioBlackRock Mutual Fund announced that it has received total investments of Rs 17,800 crore (USD 2.1 billion) across three cash/debt mutual fund schemes — the JioBlackRock Overnight Fund, JioBlackRock Liquid Fund, and JioBlackRock Money Market Fund.The new fund offer (NFO) for these three schemes was open from June 30 to July 2.
'The overwhelming response to our first NFO from institutional and retail investors is a powerful endorsement of JioBlackRock Asset Management's innovative investment philosophy, risk management capabilities, and digital-first approach. This is a strong start to our journey towards becoming a transformative force in India's evolving investment landscape, catering to all types of investors,' said Sid Swaminathan, Managing Director and CEO, JioBlackRock Asset Management.The NFOs launched by the fund house were among the largest in India's cash/debt fund segment, placing JioBlackRock Asset Management among the top 15 asset management companies by Debt Assets Under Management in the country, out of 47 fund houses.These initial offerings provide a broad range of investors with options to manage various elements of cash and short-term allocations, helping them put idle funds to work while meeting different liquidity, risk, and return objectives.
Short-duration debt and money market mutual funds offer a solution for investors seeking yield through lower-volatility, short-term instruments—without locking into long-term commitments. They provide flexibility to meet liquidity needs and are useful tools for portfolio builders, corporate treasuries, and retail investors alike, the fund house noted. JioBlackRock Asset Management has also announced an Account Creation Initiative aimed at enabling retail investors to benefit from its systematic investment approach and participate in upcoming fund offerings.
Also Read | Mazagon Dock and Radico Khaitan among 19 stocks which are upgraded in H2 CY25 Designed to simplify onboarding, the initiative allows customers to create investment-ready accounts within minutes through the JioFinance app. All a customer needs to do is download and/or open the JioFinance app, tap the 'Invest' tab at the bottom of the homepage, and begin the account creation and investment journey.Last week, the fund house announced the launch of mutual fund access on the MyJio app via its social media platforms, calling it a new era of investing.On social platform X, the fund house posted: 'A new era of investing has begun on the MyJio app.'
https://x.com/JioBlackRockmf/status/1940643190262173897
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
20 minutes ago
- Indian Express
Share price under Rs 200: Multibagger railway stock secured over Rs 1600 crore order last week
Multibagger railway stock order win: A multibagger railway PSU stock secured back-to-back orders last week, according to exchange filings. The total value of these new contracts exceeds Rs 1,600 crore. Can you guess which one? Here's a hint – as of July 20 (NSE data), this railway company has a market capitalisation of Rs 17,563.19 crore. This railway company is none other than IRCON International Limited. IRCON is a navratna company under the Ministry of Railways. Last week (July 14-18), IRCON bagged three new orders. These are as follows: In an exchange filing on July 18, the company said, 'Mumbai Metropolitan Region Development Authority has awarded the work to Ircon International Limited for CA-233, Line-6, Package-2: Design, Manufacture, Supply, Installation, Integration, Testing and Commissioning of Power Supply and Traction, E & M, Lifts & Escalators including 5 Years of Comprehensive Maintenance after 2 Years of Defect Liability Maintenance Period of Line 6 [Swami Samarth Nagar to Vikhroli (EEH)] of Mumbai Metro Rail Project of MMRDA.' The project cost is Rs 642,44,02,451.34. In a separate filing, the railway company said, ' Mumbai Metropolitan Region Development Authority has awarded the work to Ircon International Limited for CA-239, Line-5, Package-2: Design, Manufacture, Supply, Installation, Integration, Testing And Commissioning of 220 kV receiving Substation Including 220 kV, 33kV & 25kV Cabling Work, Complete 25kV Overhead Catenary System along with switching station, 33kV Auxiliary Power Distribution System Including 33/0.415 kV Auxiliary Sub-Station (ASS) And Complete SCADA System, Electrical and Mechanical works, Lift & Escalator Works for part of Main Line, Stations & Kasheli Depot of Mumbai Metro Rail Line 5 Project of MMRDA Including 5 Years of Comprehensive Maintenance after 2 Years of Defect Liability and Maintenance Period.' The project cost is Rs 471,29,72,820. In a filing on Friday, the company said, ' IRCON has been awarded with Letter of Award for the project floated by RVNL (Participated in this bid in JV mode with M/s JPWIPL (i.e., IRCON – 70% & JPIWL – 30%).' Here the total project amount is Rs 755,78,21,993.63 (IRCON Share – Rs 529,04,75,395.53),' the company said. Shares of IRCON closed in red on Friday (July 18). The PSU railway stock settled at Rs 186.74 apiece, down 1.60 per cent on NSE. IRCON International Limited is a component of the BSE 500. According to the BSE analytics (as of July 20), shares of IRCON gave negative returns in the last 1 week and 2 weeks, by 2.20 per cent and 6.27 per cent, respectively. Shares of the PSU railway stock also fell in the last 1 year by 40.25 per cent. However, in the past 2 years, 3 years, and 5 years, shares of the company rose 116.15 per cent, 405.27 per cent, and 307.03 per cent, respectively. This year, IRCON paid a dividend of Rs 1.65 in February. Last year, the PSU railway stock declared total dividends of Rs 3.10. IRCON issued bonuses in the ratio of 1:1 for the equity shareholders.
Economic Times
20 minutes ago
- Economic Times
Anthem Biosciences IPO: What GMP signals ahead of listing on Monday
Anthem Biosciences is set to debut on the stock exchanges on Monday, July 21. In the unlisted market, its shares are trading at a premium of Rs 165–170, indicating a potential listing gain of around 29% over the IPO price of Rs 570 (upper band). ADVERTISEMENT While the grey market premium (GMP) reflects strong investor interest, it remains a speculative indicator and can change quickly before listing. The Rs 3,395 crore IPO was entirely an offer for sale (OFS) and closed on July 16. It witnessed robust demand, with an overall subscription of 67.42 times. The Qualified Institutional Buyers (QIB) segment was subscribed 192.80 times, Non-Institutional Investors (NII) 44.70 times, and the retail portion 5.98 times. The issue was priced in a band of Rs 540–570 per share, with a minimum lot size of 26 shares. The stock will list on both NSE and BSE. Founded in 2006, Anthem Biosciences operates in a niche segment of the pharma value chain, offering end-to-end drug discovery, development, and manufacturing services. It is among the few Indian CRDMOs with integrated capabilities across both small molecules (chemical-based) and large molecules (biologics).Its differentiated fee-for-service (FFS) model has enabled it to cater to small and mid-sized biotech firms globally, which constitute a large portion of its client base. Since its inception, the company has served over 675 clients and completed more than 8,000 projects. ADVERTISEMENT In FY25, Anthem reported strong financials, with an EBITDA margin of 36.8% and a Return on Net Worth (RoNW) of 20.8%. As of March 2025, the company's net worth stood at Rs 2,410 facilities are cGMP-compliant and approved by global regulatory bodies such as the USFDA, ANVISA, TGA, and PMDA. The company is currently expanding its fermentation and synthesis capacities to meet growing demand for complex biologics and specialty ingredients. ADVERTISEMENT JM Financial is the book-running lead manager of the Anthem Biosciences IPO, while Kfin Technologies is the registrar for the issue. (Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Economic Times
20 minutes ago
- Economic Times
July 22–25: Critical time windows could trigger Nifty reversals, says Harshubh Shah
Indian equity markets closed lower for the third straight week, with the Nifty50 slipping 0.7% to end below the 25,000 mark for the week ending July 18, 2025.A sharp uptick in foreign institutional investor (FPI) selling has amplified the weakness. According to NSDL data, FPIs have offloaded Indian equities worth Rs 10,775 crore so far in beneath the surface of price action, a subtler force is at work: time. July 15–19: Time Levels Guide Market Moves In our previous analysis, we highlighted July 15 as a pivotal date—and the market respected this projection. On Friday, July 19, once the low of July 15 was breached, the Nifty witnessed aggressive selling. Even the high made on July 15 proved significant: a failed breakout attempt near that level on July 16 triggered fresh declines. Critical support zones worked well last week: 24,978 acted as a crucial support level before Friday's 25,085 mark (July 15's low) also played a vital role, as its breach led to a steep again, the market demonstrated that both price levels and time zones matter in short-term trading decisions. Precision in Time-Based Analysis: Intraday Accuracy Unmatched Throughout the week, time analysis proved its merit with remarkable precision. Specific intraday time slots consistently aligned with swing highs, lows, and key reversals: July 14: 10:20 AM – Swing high, followed by a downtrend 11:30 AM – Day's low formed near this time July 15: 9:45 AM – Day's low formed 2:45 PM – Swing low marked with precision July 16–18: Multiple intraday pivots around key time slots like 10:45 AM, 12:30 PM, and 2:45 PM Such consistency confirms that Time Analysis, when combined with Price Action, can provide traders with clear, actionable insights. Outlook for July 21–25: Big Moves ExpectedKey Support Zones: 24,978 / 24,850 / 24,676 / 24,538 / 24,450 Key Resistance Levels: 25,080 / 25,147 / 25,320 / 25,434 / 25,566 / 25,600 Intraday Time Slots to Watch: Key Dates to Track July 22–23: Expect swift intraday moves — ideal for short-term traders and 24–25: Watch for a potential top or bottom formation. Positional traders should stay alert. Conclusion While many traders focus solely on chart patterns, indicators, or news flow, the underlying rhythm of Time remains a powerful yet underappreciated tool. The coming week holds key signals hidden in specific time windows. Stay prepared — sharp moves could catch the unprepared off-guard. (The author is Director, Wealthview Analytics Pvt Ltd. SEBI Registration – INH000009676) (Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of The Economic Times)
